Delivery Order SPE2DE24D0013-SPE2D626F2931
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,880.04 by the Defense Logistics Agency Medical Supply Chain on October 17, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, is scheduled for completion by October 24, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as a...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,760 on July 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which carries no set-aside designation, has an ultimate completion date of July 25, 2025, and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with Cepheid's existing Indefinite...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $10,914 on September 22, 2025, by the Defense Logistics Agency's Medical Supply Chain division under the Defense Department. The firm fixed-price delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by October 6, 2025, and will be performed at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents procurement...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $8,160 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus. The award carries no set-aside designation and represents a continuation of...
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 on September 10, 2025, by the Medical Supply Chain, a defense-focused federal agency. This delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, is associated with Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with the Veterans Affairs Veterans Integrated Service Network 21, valued at $2.5...
- Cepheid, a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $18,433.60 by the Defense Logistics Agency's Medical Supply Chain division on September 22, 2025. The delivery order, which carries no set-aside designation, is scheduled for ultimate completion by September 29, 2025. This award represents a continuation of Cepheid's established relationship with federal healthcare agencies in supplying diagnostic...
- Cepheid, a molecular diagnostic solutions manufacturer headquartered in Sunnyvale, California, received a delivery order award valued at $5,443.58 under contract number XPRSMVP-10 from the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which was not set-aside for any specific business category, was awarded on August 21, 2025, with an ultimate completion date of August 28, 2025. The work will be performed in Sunnyvale, California, and represents...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $5,951.40 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order, issued on September 18, 2025, carries no set-aside designation and represents work to be performed at Cepheid's headquarters location in Sunnyvale, California. The delivery order is likely associated...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $49,896.50 on August 6, 2025, under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain division. The delivery order, which bears the contract number 4569009272 and identifier XPRS4PLEX-10, carries an ultimate completion date of August 13, 2025, and involves performance in Sunnyvale, California. This award utilizes no set-aside...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F2931Delivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,395.95 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated 4569773284 under the contract vehicle GXCT/NG-10, represents work to be performed at Cepheid's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an established federal supplier of molecular diagnostic solutions. While the specific deliverables are not detailed in the award notice, this delivery order aligns with the Defense Logistics Agency Medical Supply Chain's routine procurement of diagnostic testing supplies, test kits, and reagents that support federal healthcare operations. This delivery order falls within the context of Cepheid's extensive federal contracting history as a primary supplier of advanced molecular diagnostic systems and reagents. The company has established significant relationships across multiple federal agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard, supplying GeneXpert diagnostic platforms, PCR test kits for infectious diseases, and associated maintenance services. Cepheid's federal portfolio demonstrates particular expertise in rapid molecular diagnostic testing for COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other infectious diseases, positioning the company as a critical supplier within the federal diagnostic procurement landscape.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 10/20/25 |